Aug 18 2024 |
CNIPA: Frequently Asked Questions re Fees for Open Licensing and Patent Term Compensation |
Schwegman, Lundberg & Woessner, P.A. |
Aug 16 2024 |
Real-World Data Back in the Spotlight at FDA |
McDermott Will & Emery |
Aug 16 2024 |
CMS Rules Propose Changes Regarding the Medicare Prescription Drug Inflation Rebate Program, Refundable Drugs, Skin Supplements and More; Comments Due September 9 |
Epstein Becker & Green, P.C. |
Aug 16 2024 |
What To Expect for the IPO Market in the Second Half of 2024 |
Foley & Lardner LLP |
Aug 15 2024 |
UPSIDE Sues Florida Over Cell-Grown Meat Ban |
Keller and Heckman LLP |
Aug 15 2024 |
Recent Supreme Court Decisions and the DSCSA |
Epstein Becker & Green, P.C. |
Aug 15 2024 |
FTC Releases Controversial Interim Staff Report on PBMs’ Purported Impact on Drug Prices |
Epstein Becker & Green, P.C. |
Aug 15 2024 |
FDA Rolls Out Innovative New Designation Programs in Response to Congressional Mandates |
Mintz |
Aug 15 2024 |
No Surprises Here! Fifth Circuit Upholds Health Care Provider Challenge to No Surprises Act Regulations |
Proskauer Rose LLP |
Aug 14 2024 |
BIPA Update: Illinois Limits Liability and Clarifies Electronic Consent for Biometric Data Collection |
Greenberg Traurig, LLP |
Aug 14 2024 |
This Week in 340B: August 6 – 12, 2024 |
McDermott Will & Emery |
Aug 14 2024 |
Krazati Untitled Letter: A Cautionary Tale for CFL Promotion of Accelerated Approval Drugs |
Sheppard, Mullin, Richter & Hampton LLP |
Aug 14 2024 |
NASEM Releases Report on Infant Formula Market Challenges |
Keller and Heckman LLP |
Aug 14 2024 |
China’s State Administration for Market Regulation Releases Draft Antitrust Guidelines for the Pharmaceutical Sector Covering Reverse Payments and Evergreening |
Schwegman, Lundberg & Woessner, P.A. |
Aug 13 2024 |
Bipartisan Legislation Would Advance American Production of Renewable Chemicals |
Bergeson & Campbell, P.C. |
Aug 13 2024 |
Cancer Drugs: Antibody-Drug Conjugate Litigation |
Foley & Lardner LLP |
Aug 13 2024 |
Illinois Judge Dismisses Bottled Water False Ad Complaint |
Keller and Heckman LLP |
Aug 13 2024 |
Litigation Minute: Microplastics—Everything, Everywhere, All at Once? |
K&L Gates LLP |
Aug 12 2024 |
Alabama Awards Two Additional Cannabis Cultivation Licenses |
Bradley Arant Boult Cummings LLP |
Aug 12 2024 |
New Maine Law Will Streamline Application Process for On-Premise Liquor License |
Pierce Atwood LLP |
Aug 9 2024 |
Impact of Ohio Legal Recreational Marijuana on Employers: All Smoke and No Fire? |
Jackson Lewis P.C. |
Aug 9 2024 |
APHIS Announces New Flexibility for BRS Importation Permits in APHIS eFile |
Bergeson & Campbell, P.C. |
Aug 9 2024 |
FDA and CTTI Hold Joint Workshop on AI in Drug Development – AI: The Washington Report |
Mintz |
Aug 9 2024 |
Department of Justice (DOJ) Launches Corporate Whistleblower Awards Pilot Program |
ArentFox Schiff LLP |
Aug 9 2024 |
From Prescription Pad to Prison: Physician’s Opioid Scheme Leads to $4.7 Million Judgment |
Tycko & Zavareei LLP |
Aug 8 2024 |
FDA Releases Summary Report on Fresh Herbs Sampling Assignment |
Keller and Heckman LLP |
Aug 8 2024 |
5 Questions About Ketamine Investigations Answered |
Oberheiden P.C. |
Aug 8 2024 |
HHS-OIG Draws Legal Boundaries for Patient Caregiver Support Provided by Biotech Company |
Barnes & Thornburg LLP |
Aug 7 2024 |
FDA Will Hold Meeting in September 2024 on Development of Enhanced Systematic Process for Post-Market Assessment of Chemicals in Food, Announces Executive Career Opportunities Related to Human Foods Program |
Bergeson & Campbell, P.C. |
Aug 7 2024 |
APHIS Announces Flexibility Allowing for Reuse of BRS Import Labels |
Keller and Heckman LLP |
Aug 7 2024 |
Cal/OSHA and the Agriculture Industry: Compliance Challenges and Practice Pointers [Podcast] |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Aug 7 2024 |
Florida Division of Alcoholic Beverages and Tobacco Announces 2024 Quota Beverage License Drawing Entry Period |
Jones Walker LLP |
Aug 6 2024 |
Madam Policy: Jean Terranova, Senior Director of Policy and Research at Community Servings: Driving the Future of Nutrition & Food Security Policy [Podcast] |
Bracewell LLP |
Aug 6 2024 |
Ohio Now Has Legal Recreational Marijuana: What Employers Need to Know |
Barnes & Thornburg LLP |
Aug 6 2024 |
Unpacking Averages: Is It Too Soon to Study the Postmarket Experience of AI-Driven Medical Devices? |
Epstein Becker & Green, P.C. |